Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125631904 | 12563190 | 4 | F | 20160826 | 20160715 | 20160901 | EXP | US-PFIZER INC-2016344695 | PFIZER | 60.00 | YR | M | Y | 83.91000 | KG | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125631904 | 12563190 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, TABLET, ONCE A DAY | N | 1070621 | 20702 | 10 | MG | FILM-COATED TABLET | QD | ||||
| 125631904 | 12563190 | 2 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, 4X/DAY | 0 | 50 | MG | TABLET | QID | ||||||
| 125631904 | 12563190 | 3 | C | TRAMADOL. | TRAMADOL | 1 | UNK, AS NEEDED | 0 | TABLET | ||||||||||
| 125631904 | 12563190 | 4 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 125631904 | 12563190 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 125631904 | 12563190 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 0 | TABLET | |||||||||||
| 125631904 | 12563190 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, 2X/DAY | 0 | 100 | MG | BID | ||||||||
| 125631904 | 12563190 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK, 3X/DAY | 0 | TID | ||||||||||
| 125631904 | 12563190 | 9 | C | MELOXICAM. | MELOXICAM | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | TABLET | QD | |||||||
| 125631904 | 12563190 | 10 | C | FISH OIL | FISH OIL | 1 | 1200 MG, DAILY | 0 | 1200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125631904 | 12563190 | 1 | Blood cholesterol increased |
| 125631904 | 12563190 | 2 | Pain |
| 125631904 | 12563190 | 5 | Pain |
| 125631904 | 12563190 | 6 | Antiinflammatory therapy |
| 125631904 | 12563190 | 7 | Pain |
| 125631904 | 12563190 | 9 | Antiinflammatory therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125631904 | 12563190 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125631904 | 12563190 | Arthritis | |
| 125631904 | 12563190 | Back disorder | |
| 125631904 | 12563190 | Muscle spasms | |
| 125631904 | 12563190 | Muscle tightness | |
| 125631904 | 12563190 | Myalgia | |
| 125631904 | 12563190 | Sciatica |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125631904 | 12563190 | 1 | 201607 | 0 | ||
| 125631904 | 12563190 | 9 | 20160711 | 0 |